Health & Medicine
In 2018, there will be more than 650,000 new cases of oral, head and neck cancers diagnosed worldwide, but early screening and diagnosis can more than double a patient’s chances of survival.
UAB Medicine recently established a colorectal oncology clinic to provide a hassle-free experience for diagnosis and treatment.
Construction begins on Alabama's first proton therapy facility, bringing the most most advanced form of cancer-killing radiation to UAB in 2020.
This combination therapy, tested preclinically, could potentially improve patient outcomes.
With financing secured and site preparation underway, UAB’s Proton Therapy Center looks to begin construction in January 2018.
A UAB researcher has received a 2017 Susan G. Komen grant to investigate combination drug therapies for HER2-positive breast cancer.
UAB is the first in the country to use novel HyperArc High-Definition Radiotherapy on brain cancer patients.

The ProAssurance Endowed Chair for Physician Wellness at UAB will help address health issues unique to physicians as they deal with the stress and pressures associated with providing care in today’s evolving health care environment.

The UAB Cancer Center offers patients with advanced and rare cancer, including those with any stage of pancreatic and brain cancer, the opportunity to have no-cost tumor profiling, and patients may be matched with an appropriate clinical trial or recommend use of an FDA-approved drug.
UAB will bring proton therapy, one of the most technically advanced forms of cancer-killing radiation, to Alabama with the new Proton Therapy Center.
Donald Buchsbaum is the sixth UAB faculty member enrolled in the National Academy of Inventors.
The partnership will bring a highly effective and precise alternative to traditional radiation therapy for treating cancer and some noncancerous tumors, without many of the side effects that often accompany treatment.
Prostate cancer physicians look to provide personalized medicine to prostate cancer patients with a new medical device.
The new internal medicine and pediatric clinic will feature an outpatient diagnostic center with a cutting-edge imaging facility and full ambulatory lab services, all on-site.
UAB researcher awarded first joint AACR- TNBC Foundation Career Development Award focused specifically on triple negative breast cancer.
Elevated PARP1 polymerase in HER2+ breast cancer may confer susceptibility to PARP inhibitor drugs.
Christopher Willey receives a crucial ACS research grant to further his novel work on the MARCKS protein in relation to brain cancer.
Researchers identify the strategy that highly aggressive brain tumor cells use to fuel their relentless expansion and reveal a fresh target for cancer therapy.

In this preliminary analysis, the study treatment neither built up in organs and nor destroyed the bone marrow’s ability to make blood cells.

The Regional Oncology Active Research (ROAR) initiative of the Southeast Cancer Foundation supports radiation oncology research.

Page 1 of 2
Back to Top